PCR and NGS-Based Molecular Diagnostics Market Size, Segments, and Growth by 2031

MARKET INTRODUCTION

Molecular diagnostics includes various techniques to analyze biological markers in the genome and proteome. These techniques are used to guide patient's right from diagnosis to treatment, for diseases like cancer, infectious disease, and congenital abnormalities. These techniques help in identifying the genetic variants that have led to the disease. Molecular diagnostic procedures that are routinely used include polymerase chain reaction (PCR), real-time PCR, restriction fragment length polymorphism analysis (RFLP), fluorescence in situ hybridization, gel electrophoresis, single-stranded conformation polymorphism, hybrid capture, and other assays.

MARKET DYNAMICS

The PCR and NGS-Based Molecular Diagnostics Market is growing due to increasing prevalence of infectious diseases and different types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques. However, technical issues related to sample collection and storage and risk of contamination and complex regulatory scenario hampers growth of this market.

MARKET SCOPE

The "PCR and NGS-Based Molecular Diagnostics Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PCR and NGS-Based Molecular Diagnostics market with detailed market segmentation by product and service, application and end user. The PCR and NGS-Based Molecular Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PCR and NGS-Based Molecular Diagnostics Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The PCR and NGS-based molecular diagnostics market is segmented on the basis of product and service, application and end user. Based on product and service, the market is segmented as reagents & kits, instruments and services & software. On the basis of application, the market is categorized as infectious disease and oncology, genetic test and others. Based on end user the market is segmented into hospital & academic laboratories, reference laboratories and other

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PCR and NGS-Based Molecular Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PCR and NGS-Based Molecular Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

`The report analyzes factors affecting PCR and NGS-Based Molecular Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PCR and NGS-Based Molecular Diagnostics Market in these regions.

MARKET PLAYERS

The report covers key developments in the PCR and NGS-Based Molecular Diagnostics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PCR and NGS-Based Molecular Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for PCR and NGS-Based Molecular Diagnostics Market in the global market. Below mentioned is the list of few companies engaged in the PCR and NGS-Based Molecular Diagnostics Market.

The report also includes the profiles of key players in PCR and NGS-Based Molecular Diagnostics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Abbott
  
•  Agilent Technologies, Inc.
  
•  Thermo Fisher Scientific Inc.
  
•  F. Hoffmann-La Roche Ltd.
  
•  Bio-Rad Laboratories, Inc.
  
•  QIAGEN
  
•  bioMérieux SA
  
•  BD
  
•  Illumina, Inc.
  
•  Danaher
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

PCR and NGS-Based Molecular Diagnostics Report Scope